IDEXX Laboratories Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. 開發、生產和分銷產品，並主要爲伴侶動物獸醫、牲畜和家禽、乳製品和水檢測行業提供服務。該公司還提供人類醫療即時診斷和實驗室診斷。其部門包括伴侶動物組 (CAG)、水質產品 (水) 以及牲畜、家禽和乳製品 (LPD)。CAG 部門爲伴侶動物獸醫行業提供基於診斷和信息管理的產品和服務，包括臨牀診斷解決方案、外部參考實驗室服務以及獸醫軟件和服務。其水部門提供測試解決方案，用於準確檢測和量化水中的各種微生物參數。其 LPD 部門提供診斷測試、服務和相關儀器，用於管理牲畜和家禽的健康狀況，以提高牛奶的質量和安全性。

公司簡介

公司代碼IDXX

公司名稱IDEXX Laboratories Inc

上市日期Jun 21, 1991

成立日期1983

CEOMr. Andrew Emerson

員工數量11000

證券類型Ordinary Share

年結日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編04092-2041

電話12075560300

網址https://www.idexx.com/

公司代碼IDXX

上市日期Jun 21, 1991

成立日期1983

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Brian P. Mckeon

Chief Financial Officer, Executive Vice President, Treasurer

29.92K

+0.16%

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.43K

--

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

7.88K

--

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

+0.61%

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

5.93K

+8.90%

Mr. Daniel M. (Dan) Junius

Independent Director

2.74K

+7.24%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

2.40K

--

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Brian P. Mckeon

Chief Financial Officer, Executive Vice President, Treasurer

29.92K

+0.16%

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.43K

--

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

7.88K

--

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

+0.61%

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

5.93K

+8.90%

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

3.13B

80.29%

Reference laboratory diagnostic and consulting services

1.34B

34.28%

IDEXX VetLab consumables

1.30B

33.44%

Rapid assay products

359.75M

9.23%

CAG Diagnostics capital - instruments

312.62M

8.02%

Other

-2.54B

-65.27%

地區USD

名稱

營收

佔比

United States

2.53B

64.99%

Other Euorpe

196.31M

5.04%

Germany

173.68M

4.46%

Canada

152.88M

3.92%

United Kingdom

134.63M

3.45%

Other

706.82M

18.14%

業務

地區

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

3.13B

80.29%

Reference laboratory diagnostic and consulting services

1.34B

34.28%

IDEXX VetLab consumables

1.30B

33.44%

Rapid assay products

359.75M

9.23%

CAG Diagnostics capital - instruments

312.62M

8.02%

Other

-2.54B

-65.27%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

11.94%

BlackRock Institutional Trust Company, N.A.

6.57%

State Street Global Advisors (US)

4.49%

Fundsmith LLP

3.29%

Geode Capital Management, L.L.C.

2.83%

Other

70.88%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

11.94%

BlackRock Institutional Trust Company, N.A.

6.57%

State Street Global Advisors (US)

4.49%

Fundsmith LLP

3.29%

Geode Capital Management, L.L.C.

2.83%

Other

70.88%

股東類型

股東統計

佔比

Investment Advisor

41.57%

Investment Advisor/Hedge Fund

40.96%

Research Firm

3.74%

Pension Fund

2.27%

Hedge Fund

2.19%

Bank and Trust

1.79%

Sovereign Wealth Fund

1.34%

Individual Investor

0.67%

Family Office

0.46%

Other

5.00%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

2216

76.97M

94.97%

-4.38M

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

2022Q4

2124

77.44M

93.49%

-2.66M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

9.67M

11.94%

-29.32K

-0.30%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

5.32M

6.57%

-239.97K

-4.31%

Dec 31, 2024

State Street Global Advisors (US)

3.64M

4.49%

+24.20K

+0.67%

Dec 31, 2024

Fundsmith LLP

2.66M

3.29%

-1.31K

-0.05%

Dec 31, 2024

Geode Capital Management, L.L.C.

2.30M

2.83%

+37.73K

+1.67%

Dec 31, 2024

Baron Capital Management, Inc.

2.01M

2.47%

+82.26K

+4.28%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

1.69M

2.09%

+22.74K

+1.36%

Feb 28, 2025

AllianceBernstein L.P.

1.24M

1.53%

-1.58M

-56.02%

Dec 31, 2024

BlackRock Asset Management Ireland Limited

1.13M

1.39%

+36.40K

+3.33%

Dec 31, 2024

Principal Global Investors (Equity)

711.20K

0.88%

-19.27K

-2.64%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

ProShares Pet Care ETF

9.82%

iShares U.S. Medical Devices ETF

3.79%

First Trust Water ETF

3.75%

Acquirers Fund

3.67%

Inspire Tactical Balanced ETF

2.66%

First Trust S&P 500 Economic Moat Index ETF

1.99%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

1.81%

American Century Mid Cap Growth Impact ETF

1.79%

Tema Monopolies and Oligopolies ETF

1.64%

Invesco S&P 500 Equal Weight Health Care ETF

1.58%

ProShares Pet Care ETF

佔比9.82%

iShares U.S. Medical Devices ETF

佔比3.79%

First Trust Water ETF

佔比3.75%

Acquirers Fund

佔比3.67%

Inspire Tactical Balanced ETF

佔比2.66%

First Trust S&P 500 Economic Moat Index ETF

佔比1.99%

First Trust NASDAQ-100 Ex-Technology Sector Index Fund

佔比1.81%

American Century Mid Cap Growth Impact ETF

佔比1.79%

Tema Monopolies and Oligopolies ETF

佔比1.64%

Invesco S&P 500 Equal Weight Health Care ETF

佔比1.58%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

IDEXX Laboratories Inc

470.865USD

IDEXX Laboratories Inc

470.865

概覽

公司